| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 2026-04-06 | 58,292 | $9.59 | $559.02kBuy |
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 2026-04-06 | 27,610 | $204.87 | $5.66MSell |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 2026-04-01 | 1,200 | $203.83 | $244.59kSell |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 2026-04-01 | 300 | $200.79 | $60.24kSell |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 2026-04-01 | 1,778 | $202.01 | $359.17kSell |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 2026-04-01 | 3,213 | $203.07 | $652.47kSell |
| Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2026-04-01 | 1,048 | $201.32 | $210.98kSell |
| Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2026-04-01 | 1,000 | $202.36 | $202.36kSell |
| Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2026-04-01 | 952 | $203.31 | $193.55kSell |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 2026-04-01 | 1,909 | $205.00 | $391.35kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jpmorgan Chase Co | 9.07% | 12,854,334 | $2.71B | Institution |
| Vanguard Group Inc | 8.68% | 12,306,424 | $2.59B | Institution |
| Price T Rowe Associates Inc | 7.67% | 10,871,989 | $2.29B | Institution |
| Blackrock Inc | 7.66% | 10,859,441 | $2.29B | Institution |
| Claremont Creek Ventures L P | 4.14% | 5,864,630 | $1.24B | Insider |
| Roelof Botha | 3.96% | 5,609,181 | $1.18B | Insider |
| Sc XII Management LLC | 3.82% | 5,421,122 | $1.14B | Insider |
| Wellington Management Group LLP | 3.51% | 4,976,325 | $1.05B | Institution |
| Matthew Rabinowitz | 3.47% | 4,911,730 | $1.04B | Insider |
| James Healy | 3.31% | 4,697,100 | $990.29M | Insider |